Date:8/17/2011

surgery and we are pleased to collaborate with Stryker Orthopaedics to turn this new field into a reality," said Jay Pierce, CEO of OrthoSensor. "Until now, surgeons have lacked quantifiable data about joint kinematics and their decisions varied based on individual judgment, experience and skill set. OrthoSensor's intelligent surgical systems will provide surgeons, hospitals and health plans access to real-time data to improve patient care, measure clinical outcomes and lower costs related to treating musculoskeletal disease."

About Stryker OrthopaedicsStryker Orthopaedics is a division of the Stryker Corporation, one of the world's leading medical technology companies. Stryker Orthopaedics offers an extensive orthopaedic product portfolio including hip, knee and upper extremity reconstructive devices, bone cement, trauma implants, bone substitutes and spine systems. For more information about Stryker Orthopaedics, visit: http://www.stryker.com/en-us/products/Orthopaedics/index.htm

About StrykerStryker is one of the world's leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. For more information about Stryker, please visit www.stryker.com.

About OrthoSensor, Inc. OrthoSensor, Inc. (www.orthosensor.com) is an innovative medical device company developing and commercializing intelligent orthopaedic devices that provide real-time data to surgeons and hospitals during and after surgery.  OrthoSensor's intelligent orthopaedic devices utilize advanced sensor and wireless
'/>"/>

SOURCE Stryker Orthopaedics Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. Landmark Stryker Trial Establishes Coiling as Safe and Effective Treatment for Ruptured and Unruptured Aneurysms
2. Stryker Ends Distribution Agreement With Corin PLC
3. Stryker Announces Exclusive Collaboration With RegenLab
4. Stryker Launches VersiTomic G-Lok™
5. Stryker Orthopaedics Launches Its First iPad™ Apps for Surgeons, Available Through Apples App Store(SM)
6. Stryker Features Tissue-Preservation Hip Arthroscopy Platform, Sponsors Surgeon Education Events at the AAOS Annual Meeting
7. Fred Funk Becomes Spokesperson for Stryker Orthopaedics
8. Stryker Receives FDA 510(k) Clearance to Market Modular Dual Mobility Acetabular (Hip) System
9. Stryker Declares a $0.18 Per Share Quarterly Dividend
10. Stryker Completes Sale of OP-1 for use in Orthopaedic Bone Applications to Olympus
11. Stryker Reports 9% Sales Growth, 13% Adjusted Net Earnings Growth for Quarter Ended December 31, 2010